Abstract -In this highly cornplex interdisciplinary area of biornedical polymers, progress is beginning to be nade in a variety of implants. Of probable major iinportance is that of S!I13.ll diameter blood vessel repair. The studies leading to the development of a S!I13.ll diameter vascular graft are discussed to show the interrelationship between polYJII7r surfac: and rulk ~hology, polymer-protein interaction, platelet adhes1.on, and llllplant mechan1.cal properties on the perfonnance of the implant in the body.
A variety of polymeric implants have been tried for repair or replacement of darnaged or diseased tissues and organs. Initially these implants used polymeric rnaterials developed for other, non-biological applications. As a result, the implants, at best, worked in linuted situations, and at worst failed. During this last decade, we have seen a tremendous increase in research on the development of polymer rnaterials for biamedical applications. While some scientific progress has been nade, there has not been an accornpanying progr>ess in the clinical and surgical utilization of these biornedical inaterials. fuch of this has resulted from a lack of coupling between research in bicmediccil. rnaterials and the development studies related to the end-use applications. If we are to realize the potential in this area in which implant rnaterials are used to restore structure and function of the body, a variety of modified or new rna.terials, designed specifically for use in the body, are needed. However, this requires gaining an understanding of how polymer rnaterials and the biological system interact at the molecular level and the rnacroscopic (or implant) level.
In this highly ccmplex interdisciplinary area, progr>ess is beginning to be rnade in a variety of implants. With the variety of excellent papers being presented in this section of the program, I will limit myself to discussing the development of a srnall diameter vascular gr>aft, and show the interrelationship between polymer surface and rulk rrorphology, polymer-protein interaction, implant mechanical properties, and polymer degr>adation on implant performance.
The ultirnate goal of these studies is the development of satisfactory replacement rnaterials for damaged or obstructed veins or S!I13.ll diameter (less than 5 rrm) arteries. The need for such a prosthesis is not only in the area of peripheral vascular surgery where it is necessary for bypassing arterial obstruction, but also in aorta-coronary surgery where it is estimated 100,000 operations requiring srnall diarneter vessels will be perfarmed in 1977. Currently, the surgeon is forced to use autogenaus tissue such as the saphenous vein in these situations. This method has disadvantages in that satisfactory veins are not available in 10 to 25% of patients. Even in patients having satisfactory veins, one is limited in the size and quality available with removal of the veins requiring increased operating time. Therefore, the solving of this problern would be of significance to the surgeon and to the patient. · Currently, available synthetic polymer gr>afts are nade from expanded porous Teflon and Dacron. These rnaterials show patency rates of approximately 50% at the 6 rrm ID size arrl IIUlch less at smaller diameters. Thus, one IIUlst search for new polymers that will show an increase in patency rat es in small diameter vessels.
There appears to be ample evidence from our studies and those of others to support the contention that protein adsorption is the first event oc~ing as blood cames in contact with a polymer surface in vivo (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Platelets then adhere to this prcteinated polyner surface to varying degrees-rl~ Studies on the adhesion of platelets to polymer surfaces precoated with a variety of proteins have indicated that albuminated surfaces appear to prevent platelet adhesion and confer non-thrombogencity to the basepolymer (9, 12, 13) . In contrast, surfaces pre-coated with fibrinogen or y-globulin show increased platelet adhesion arrl release reactions leading to thrombosis (1, 10, 12, (14) (15) (16) (17) (18) (19) . One is lead to the hypothesis thex the composition of the protein layer forrned in situ as whole blood flows over a polymer surface is not necessarily the same for evecy polymer, since the degree of platelet adhesion varies from polymer to polymer (ll). The data from electrcphoretic analyses of proteins desorbed from several polymers exposed to whole blood in situ, compared with platelet adhesion rneasurements on these same surfaces using our ex-v1vo flow-thrcugh cell (9,11) (see Table l ), parallel that described above for the pre-proteinated surfaces, that is, if the polymer preferentially adsorbs alburnin in situ, it shows less platelet adhesion and the polymer should be non-thrombogenic. Conversely, a polymer preferentially adsorbing globulins or fibrinogen adheres platelets readily and should be thrornbogenic. Thus, if one cornpares the three generally different materials, i.e. the thrornbogenic fluorinated ethylene/propylene copolymer, the mildly thrombogenic polydimethyl siloxane, and the nonth:iumbogenic copolyether-urethane, the observed in vivo results of these materials correlate with the protein adsorption and platelet adhesion data. The selectivity of protein adsorption appears to be dictated by the chemical and physical structure of the polymer surface; and it is this selectivity which determines the thrornbogenic response of the base polymer (l). 2 The rnean nurnber of platelets adhering to 20,000 / surface area exposure to whole blood in the flow thrcugh ex vivo cell at various exposure times (1) .
It is also interesting to note that not all block copolyether-urethanes are non-thrombogenic. Even a minor change in the size of the ether block (as shown in PEUU 710 versus 1025 in which the m:>lecular weight of the polyether segment changes from 700 to 1000) does affect protein adsorption, platelet adhesion, and the observed thrcmbogenicity. Chemical or physical changes in the blocks can influence the domain-matrix relationships of this type of copolymer and thus affect their surface interactions. And as we will see later, changes in fabrication variables can also influence the domain-matrix relationships.
On the basis of these results, we proposed the following mechanism for the in vivo initiation of a thrornbus on a polymer surface (1, 20, 21) .
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Since Silastic Rubber adsarbs 70% alburnin on its surface and yet is mildly thrombogenic, one might estirnate that the albumin content on the surface IIIUst be grea.ter than 70% of the total protein adsorbed if the polymer is to be non-thrc:rnbogenic.
Two copolyether-urethanes, one based on polypropylene glycol (PEUU 1025M, synthesized in our labaratory) and one based on polytetramethylene glycol (the conrnercially available Biomer), have shawn improved thrombo-resistance in all tests including the Gott ring test (13, 22) . Both of these urethane naterials fit our proposed clotting mechanism in that they preferentially adsarb alburnin in situ and therefare, should be non-thranbogenic. The first srnooth urethane artificial heart61iilplanted in calves were fabricated from PEUU 1025 synthesized in our laboratory (22) ; and rnore recently, our Division of Artificial Organs has had several long term survivals (over 123 days) in calves with a total :implanted artificial heart ma.de from srnooth films of Biomer with no detectable blood danage. This is in contrast to a Silastic Rubber (and fiber-coated Silastic Rubber) heart in which extensive blood darnage does occur (23) . Thus, if these naterials are truly canpatible, as these in vitro, ex vivo and in vivo tests indicate, we should be able to use snall prostheses ma.deof this nater1al in snall diameter vessel replacement.
We fabricated and :implanted a series of solid wall vascular grafts which had been solventcast over polished alurninum and glass mandrels. One set consisted of a thin, srnooth inner wall with an external coating of the foaJ!Ed urethane, while the other set had a foaJIEd inner wall. The inferior vena cava (below the diaphragm) of dogs was initially chosen as the :implantation site since it presents the rnost severe test. Wark by others (24) (25) (26) (27) have shawn the grea.t tendency of all types of grafts, even autografts, to becone occluded t.hen :implanted here.
Our initial series of grafts also thrombosed, but the clots were found adhering to the suture-line junction beginning at the distal ar outflow end and extending down to the proxinal ar inflow end of the vein. Again, the thrornbus was not adherent to the copolyurethane. Since our earlier studies on the effect of blood flow rates on platelet adhesion indicated that the najar difference between platelet adhesion in arterial and venous systerns was the difference in flow rates (28), we investigated the effect of creating an AV fistula in the fernoral artery-vein priar to cornpleting the graft anastanoses. Our results with this procedure showed significant :improvement. Several 8 lllll (ID) grafts were patent for five weeks as determined by vena cavagrams. However, the grafts on removal still had thrombus on the suture-line junction. This appeared to be well arganized and 'iW:l.S often non-occlusive. Similar results, i. e. well arganized thrornbus at the naturalartificial artria anastOJroses, were also noted in the artificial heart :implantation experirrents.
These :implant studies plus the microscopic examinations of tissue-graft sections of a series of fernoral artery vascular :implants have suggested that the m:xie of failure might be due to a compliance mismatch between the natural vessel and the synthetic vascular graft, and not a surface incanpatibility of the copolyether-urethane with blood. [Note: This mismatch of mechanical prx::>perties appears to be a contributer in material rejection throughout the body, and not just in the vascular replacements. ]
Most vascular prx::>stheses in use today have an elastic rnoduli about ten times greater than that of the natural vessel (29) . Thus, an anastomosis between such a prx::>sthesis and a natural vessel results in a rilismatch of canpliance. Stresses are set up thrx::>ugh the generation of turbulent flow and by mechanical trauma to the natural vessel, which may contribute to suture line disruption and/or thrombosis (29, 30) . It has been shown (30) that these forces are at a minirrn.un when the ratio of Dacrx::>n graft to host artery radius is l. 4; and therefore, compensation for the compliance mismatch may be an important factor in early patency rates for current synthetic grafts. Also, since the compliance of current synthetic arterial grafts have been shown to decrease with time (31), compliance mismatch may be implicated as a possible factor in later failure rates.
Other investigators (32) have laminated films of similar copolyurethane materials to form tubes having lateral to longitudinal compliance ratios similar to the ratios found in the natural vessel as a rx::>ute to canpatible grafts. However, these materials are still too stiff and do not match the actual compliance of the vessel (see Figure 1) . We felt that it was necessary to match the actual compliance of the blood vessel in the lateral dimension if we are to achieve a successful implant. To do this required either a new block copolymer or a new fabrication method to modify the bulk structure of our material. Our ini tial studies emphasized this latter approach, although we were concerned wi th how any changes in fabrication variables might adversely affect the surface structure of our copolymer. For example, it has been reported that the siloxane-urethane material "Avcothane" can be relatively thrx::>mbogenic or non-thrombogenic depending on whether one examines the mold side or the air side of the formed material (33) . Similar, but more subtle differences between the glass mold and air side of films have been observed for our copolyurethanes by cell culture (34) and more recently by Electrx::>n Spectrx::>scopy for Chemical Analysis (ESCA) and by Fourier Transform Infrared Spectroscopy (FTIR) ( 35) .
Other variables such as type of solvent, percent polymer in solution, method of solvent removal, etc., can also influence how these block copolymers form their domain-matrix relationship.
The ESCA carbon peaks of the three polyurethanes which differ only in the molecular weight of the polypropylene glycol block, are shown in Figure 1 , illustrating the differences in ESCA spectra due to fabrication (glass versus air surface) and synthetic structure. The differenct chemical structures for the various surfaces are evident in the varying peak areas, although the ratios of peak area to theoretical values give more exciting information about the importance of fabrication variables on surface structure. Although the 2025 polyether-urethane contains twice the number of ether linkages in the bulk, it actually has less sigma bonded carbon-oxygen on the surface than the 1025 or 710 polyetherurethanes. Thus, the surface structure of an implant is not necessarily represented by the bulk structure and is greatly dependent upon the fabrication techniques.
For actually rnodeling the structure of the surface, FTIR is prx::>ving to be a better tool, especially when reflectance spectroscopy (ATR) is coupled to the subtractive capabilities of the instrument (35) . For example, a striking difference is noted in the conformation of the ether linka.ges in the soft segment comprising the matrix, Bellamy (36) describes the trans conformation of the antisymmetric C-0-C having an absorbance peak at 1120 cm-1 , while the gauehe is at 1068cm-1 • The ether absorbance peak is quite brx::>ad with the various conformational peaks forming shoulders. Subtraction of polypropylene glycol (the actual intermediate used in synthesis of the polyurethanes) from bulk and surface ATR spectra of the same film indicate a predominance of trans in the bulk as compared to gauehe in the near surface of the film as illustrated in Figure 2 .
We have now developed a new process for fabricating the copolyurethane material into an essentially nonparaus void containing graft (with reduced wall density) whose compliance can be made to apprx::>ximate that of the natural artery or vein ( 37) , and yet maintain a blood compatible surface. To imprx::>ve the Suturability of the grafts a fabric network was provided in the graft wall. Although the fabric network stiffens the graft somewhat, this composite graft still approximates the compliance of the natural artery ( Figure 1 ).
Two series of these grafts, a total of 11 grafts, ranging in size from 3 rnm to 10 mm, were implanted in dogs. Patency was followed by palpitation of femoral pulses in the case of the aortic grafts and by palpitation of distal femoral pulses in the case of the femoral grafts. The dogs were sacrificed when, on the basis of diminished or absent distal pulses, it was felt that the prx::>sthesis had failed. In cantrast to the failure of the earlier solid wall gra:fts, within hours, six of the 11 new compliant copolyether-urethane grafts were patent on sacrifice (37) . For example, an 8 rnm aortic graft was patent at 30 days and a 4 rnm femoral graft was patent at 77 days. The heavy fibrx::>tic reaction noted on the earlier solid wall non-canpliant grefts was not seen on these patent cornpliant grefts of the current series. Since the grefts were widely patent on recovery, it is believed that they would have :remained patent for a ßD.lch longer time, had the animals not been sacrificed. Of the five failures, tw:> were considered technical failures due to a twisted graft and a graft too small for the natural vessel. The other three failures were of a type similar to those of the earlier solid wall greft, suggesting either a quality control error, a technical error (surgery), possible residual solvent (N,N-dimethylforamide is toxic to cells), or some other unknown tissue reaction. However, since the :rrajor variable tested in this study was the increased elasticity (or cornpliance) of the prosthesis, we feel that this was directly responsible for our greatly improved results.
In a current series of 4 nm vascular irnplants, 17 of 38 were patent on removal or are presently in the re:rraining dogs at 13 :rronths implantationtime (38) . Patency was determined at various time intervals by exposure and direct visualization of the vessel. The one technical failure was due to the wrong suture and needle being used, resulting in tearing of the natural vessel. Pathologies on several of the removed grafts indicated the general hypertrophy leading to occlusion of the greft appeared to be due to how the anasto:rrosis was performed, with a butt type of junction being the worst. There was no foreign body type of cell response noted, and so it would appear that the failures continue to be a result of mis:rratch of graft-vessel ccmpliance, possibly cornplicated by surgical techniques, and irTegularities in graft quality. However, the long term success in these small diameter vessels does show that we Im.lSt balance the surface properties needed for bloa:l. canpatibility with the correct mechanical properties needed for compliance :rratching.
Similar types of research coupling basic study on polymer/living system interactions with actual irnplant development, are underway in ureter repair and nerve repair. 
